CEFTAZIDIME

CEFTAZIDIME was reported 7751 times

CEFTAZIDIME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR PSEUDOANEURYSM THROMBOSIS 10 0.3704
1 INFECTIVE CORNEAL ULCER 7 0.2500
2 MYCOBACTERIAL PERITONITIS 22 0.2316
3 CHOROIDITIS 76 0.2032
4 ARTERIAL ANGIOPLASTY 5 0.1852
5 FLAVOBACTERIUM INFECTION 8 0.1818
6 MYCOBACTERIUM FORTUITUM INFECTION 25 0.1351
7 INFECTIVE KERATITIS 8 0.1127
8 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 38 0.1000
9 ARTERITIS INFECTIVE 5 0.0820
10 ENDOMETRIAL DISORDER 32 0.0775
11 PARASPINAL ABSCESS 12 0.0774
12 MYOCARDIAL CALCIFICATION 9 0.0769
13 PSEUDOENDOPHTHALMITIS 7 0.0707
14 CONGESTIVE HEPATOPATHY 28 0.0625
15 HEPATOSPLENIC CANDIDIASIS 9 0.0612
16 BACTERIAL ENDOPHTHALMITIS 14 0.0526
17 ENTEROCOCCUS TEST POSITIVE 34 0.0525
18 PSEUDOMONAL BACTERAEMIA 43 0.0504
19 KERATITIS BACTERIAL 8 0.0491
20 MYCOTIC ENDOPHTHALMITIS 9 0.0476
21 GEOTRICHUM INFECTION 10 0.0474
22 VARICELLA VIRUS TEST POSITIVE 8 0.0471
23 ADENOVIRAL HEPATITIS 11 0.0468
24 STENOTROPHOMONAS TEST POSITIVE 6 0.0448
25 APLASTIC ANAEMIA 219 0.0419
26 INTRAOCULAR PRESSURE TEST 10 0.0417
27 NECROTISING SCLERITIS 6 0.0414
28 MORAXELLA INFECTION 11 0.0401
29 SCEDOSPORIUM INFECTION 28 0.0397
30 EYE EXCISION 8 0.0390
31 PARENTERAL NUTRITION 9 0.0390
32 GASTROENTERITIS STAPHYLOCOCCAL 6 0.0382
33 HERPES ZOSTER REACTIVATION 10 0.0382
34 PROTEUS TEST POSITIVE 8 0.0357
35 DYSBIOSIS 29 0.0353
36 CARDIAC VALVE VEGETATION 17 0.0350
37 FUNGAL SEPSIS 29 0.0349
38 CANDIDA PNEUMONIA 11 0.0341
39 BANDAEMIA 5 0.0340
40 HYPOPYON 28 0.0338
41 ENDOPHTHALMITIS 199 0.0331
42 TRICHOSPORON INFECTION 13 0.0321
43 EYE INFECTION FUNGAL 12 0.0310
44 FUNGAL ENDOCARDITIS 9 0.0299
45 DISTAL INTESTINAL OBSTRUCTION SYNDROME 10 0.0297
46 NONINFECTIOUS PERITONITIS 7 0.0288
47 ABSCESS FUNGAL 5 0.0286
48 BURKHOLDERIA CEPACIA COMPLEX INFECTION 8 0.0280
49 PERIPHERAL SENSORIMOTOR NEUROPATHY 33 0.0263
50 ASPERGILLUS TEST POSITIVE 8 0.0260
51 VENOUS HAEMORRHAGE 8 0.0258
52 CONGENITAL APLASIA 8 0.0257
53 CNS VENTRICULITIS 8 0.0245
54 ENTEROBACTER SEPSIS 9 0.0243
55 FUNGAEMIA 38 0.0241
56 PSEUDOMONAS TEST POSITIVE 19 0.0232
57 RESPIRATORY GAS EXCHANGE DISORDER 8 0.0216
58 DISSEMINATED MUCORMYCOSIS 8 0.0203
59 FUNGAL TEST POSITIVE 7 0.0199
60 SPLENIC ABSCESS 8 0.0197
61 ACINETOBACTER INFECTION 21 0.0192
62 HYPOCAPNIA 8 0.0191
63 STATUS ASTHMATICUS 9 0.0191
64 SYSTEMIC MYCOSIS 22 0.0188
65 HEPATIC INFARCTION 7 0.0186
66 SCROTAL PAIN 10 0.0185
67 LUNG TRANSPLANT REJECTION 12 0.0182
68 CAECITIS 8 0.0178
69 PSEUDOMONAL SEPSIS 31 0.0177
70 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 22 0.0177
71 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 9 0.0176
72 PATHOGEN RESISTANCE 156 0.0171
73 MYELOPATHY 32 0.0168
74 CHOROIDAL DETACHMENT 9 0.0162
75 GENERALISED BULLOUS FIXED DRUG ERUPTION 6 0.0161
76 PSEUDOMONAS INFECTION 137 0.0160
77 CORNEAL PERFORATION 10 0.0158
78 GRAFT VERSUS HOST DISEASE IN SKIN 34 0.0154
79 RETINAL VASCULITIS 18 0.0151
80 EMBOLIC CEREBRAL INFARCTION 10 0.0151
81 RED BLOOD CELL TRANSFUSION 6 0.0146
82 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 30 0.0141
83 DELAYED GRAFT FUNCTION 10 0.0141
84 MYCOBACTERIUM ABSCESSUS INFECTION 10 0.0140
85 GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0140
86 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 75 0.0138
87 RESPIRATORY TRACT HAEMORRHAGE 8 0.0134
88 BRADYARRHYTHMIA 21 0.0128
89 BLOOD PRESSURE DIASTOLIC ABNORMAL 32 0.0126
90 MULTIPLE-DRUG RESISTANCE 39 0.0126
91 FUNGAL PERITONITIS 19 0.0125
92 HAEMOPERITONEUM 10 0.0125
93 CANDIDA SEPSIS 11 0.0123
94 INFECTIVE ANEURYSM 6 0.0121
95 KLEBSIELLA INFECTION 61 0.0121
96 FIBROSIS 37 0.0120
97 DEVICE RELATED SEPSIS 24 0.0119
98 HYPOGONADISM 12 0.0119
99 CYTOMEGALOVIRUS ENTEROCOLITIS 9 0.0117
100 HYPOPROTEINAEMIA 22 0.0116
101 ASPERGILLOSIS 15 0.0115
102 PERIPHERAL NERVE INJURY 10 0.0114
103 WOUND DRAINAGE 9 0.0113
104 EROSIVE DUODENITIS 9 0.0112
105 CORYNEBACTERIUM INFECTION 6 0.0112
106 PROTEUS INFECTION 8 0.0111
107 ENTEROCOCCAL SEPSIS 9 0.0111
108 STENOTROPHOMONAS INFECTION 15 0.0111
109 HYPERBILIRUBINAEMIA 114 0.0110
110 RENAL ABSCESS 9 0.0110
111 CHORIORETINITIS 7 0.0109
112 LISTERIOSIS 12 0.0108
113 VANISHING BILE DUCT SYNDROME 12 0.0108
114 APLASIA 21 0.0107
115 AMAUROSIS 9 0.0107
116 CATHETER SITE RELATED REACTION 8 0.0107
117 URINARY TRACT INFECTION FUNGAL 6 0.0105
118 BACTERIAL SEPSIS 34 0.0104
119 PNEUMONIA PSEUDOMONAL 16 0.0104
120 PSEUDOMEMBRANOUS COLITIS 23 0.0103
121 OTOTOXICITY 19 0.0103
122 METAPNEUMOVIRUS INFECTION 8 0.0102
123 BONE MARROW TOXICITY 12 0.0101
124 PLATELET TRANSFUSION 13 0.0101
125 EMBOLIA CUTIS MEDICAMENTOSA 8 0.0101
126 FUSARIUM INFECTION 7 0.0100
127 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 38 0.0099
128 ANTERIOR CHAMBER CELL 7 0.0098
129 MICTURITION DISORDER 34 0.0098
130 ASPERGILLUS INFECTION 64 0.0097
131 DEMYELINATING POLYNEUROPATHY 10 0.0097
132 LINEAR IGA DISEASE 16 0.0096
133 NEPHRITIS INTERSTITIAL 12 0.0095
134 EOSINOPHILIC PNEUMONIA ACUTE 8 0.0092
135 MUCORMYCOSIS 24 0.0092
136 FEBRILE BONE MARROW APLASIA 37 0.0087
137 SPUTUM CULTURE POSITIVE 7 0.0086
138 AORTIC CALCIFICATION 5 0.0086
139 PROCALCITONIN INCREASED 10 0.0085
140 PNEUMONIA CRYPTOCOCCAL 8 0.0085
141 ANTERIOR CHAMBER INFLAMMATION 5 0.0084
142 SUBCUTANEOUS EMPHYSEMA 8 0.0081
143 VITRITIS 15 0.0081
144 BRONCHOPULMONARY ASPERGILLOSIS 62 0.0080
145 TOXIC EPIDERMAL NECROLYSIS 121 0.0080
146 SEPTIC SHOCK 340 0.0078
147 DEBRIDEMENT 6 0.0078
148 LYMPHOCYTE STIMULATION TEST POSITIVE 6 0.0075
149 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
150 LARGE INTESTINE INFECTION 9 0.0073
151 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 6 0.0073
152 DRUG RESISTANCE 180 0.0070
153 HEPATIC HAEMORRHAGE 6 0.0070
154 MUCOSAL INFLAMMATION 183 0.0070
155 HEPATIC NECROSIS 26 0.0069
156 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
157 QUADRIPLEGIA 14 0.0068
158 PANCREATIC FAILURE 12 0.0068
159 CLOSTRIDIUM DIFFICILE COLITIS 72 0.0068
160 SYSTEMIC CANDIDA 17 0.0068
161 NEUTROPENIC COLITIS 14 0.0068
162 CYTOGENETIC ANALYSIS ABNORMAL 7 0.0067
163 DISSEMINATED INTRAVASCULAR COAGULATION 94 0.0067
164 HYPOPERFUSION 7 0.0067
165 BLOOD MAGNESIUM INCREASED 6 0.0067
166 CATARRH 6 0.0066
167 ENTEROCOCCAL INFECTION 32 0.0066
168 ENTEROCOCCAL BACTERAEMIA 7 0.0066
169 MUSCLE NECROSIS 6 0.0066
170 CLOSTRIDIUM COLITIS 8 0.0066
171 LICHENOID KERATOSIS 15 0.0066
172 MULTIPLE ORGAN DYSFUNCTION SYNDROME 186 0.0066
173 STAPHYLOCOCCAL SEPSIS 32 0.0065
174 RENAL TUBULAR DISORDER 18 0.0064
175 RENAL TUBULAR NECROSIS 62 0.0063
176 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 7 0.0063
177 VENOOCCLUSIVE LIVER DISEASE 31 0.0063
178 NOCARDIOSIS 16 0.0063
179 FOETAL GROWTH RESTRICTION 38 0.0062
180 RENAL INFARCT 9 0.0062
181 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 159 0.0062
182 PULMONARY HAEMORRHAGE 48 0.0061
183 HYPERAEMIA 12 0.0061
184 SPUTUM RETENTION 6 0.0061
185 GUILLAIN-BARRE SYNDROME 29 0.0060
186 BILIRUBIN CONJUGATED INCREASED 14 0.0060
187 PNEUMONIA KLEBSIELLA 11 0.0060
188 GRAFT VERSUS HOST DISEASE 43 0.0060
189 ENTEROBACTER INFECTION 10 0.0059
190 ESCHERICHIA SEPSIS 17 0.0059
191 CUTANEOUS VASCULITIS 21 0.0057
192 BLAST CELL COUNT INCREASED 6 0.0057
193 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
194 ABDOMINAL SEPSIS 5 0.0057
195 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0057
196 HAEMORRHAGIC DISORDER 6 0.0055
197 LIP HAEMORRHAGE 7 0.0055
198 MULTI-ORGAN FAILURE 94 0.0054
199 INTRAOCULAR PRESSURE INCREASED 69 0.0054
200 CORNEAL OEDEMA 12 0.0053
201 KLEBSIELLA SEPSIS 6 0.0053
202 ACUTE LYMPHOCYTIC LEUKAEMIA 15 0.0053
203 PATENT DUCTUS ARTERIOSUS 21 0.0053
204 BLOOD FIBRINOGEN DECREASED 6 0.0053
205 LIVER ABSCESS 17 0.0052
206 SPLENIC INFARCTION 9 0.0052
207 BRAIN ABSCESS 13 0.0051
208 EOSINOPHILIA 90 0.0051
209 HYPOCHLORAEMIA 6 0.0051
210 CLONUS 14 0.0051
211 ULCERATIVE KERATITIS 14 0.0051
212 JOINT EFFUSION 35 0.0051
213 CHOLESTASIS 97 0.0050
214 PERITONEAL HAEMORRHAGE 7 0.0050
215 RASH MACULO-PAPULAR 112 0.0050
216 UVEITIS 68 0.0050
217 BRONCHIAL HYPERREACTIVITY 6 0.0050
218 MYOPATHY 43 0.0050
219 ATYPICAL MYCOBACTERIAL INFECTION 7 0.0049
220 CYSTIC FIBROSIS 27 0.0049
221 TOXIC SKIN ERUPTION 49 0.0049
222 QUADRIPARESIS 8 0.0048
223 PRODUCT CONTAMINATION 17 0.0048
224 HAEMOLYTIC URAEMIC SYNDROME 11 0.0047
225 HAEMODYNAMIC INSTABILITY 36 0.0047
226 BRONCHIAL SECRETION RETENTION 6 0.0047
227 SEIZURE LIKE PHENOMENA 8 0.0047
228 ASTERIXIS 5 0.0047
229 BLOOD CULTURE POSITIVE 14 0.0047
230 AMAUROSIS FUGAX 5 0.0046
231 PNEUMONIA CYTOMEGALOVIRAL 9 0.0046
232 ESCHERICHIA INFECTION 38 0.0046
233 CLOSTRIDIUM TEST POSITIVE 10 0.0045
234 GENERALISED OEDEMA 56 0.0045
235 CANDIDA INFECTION 76 0.0045
236 ELECTROCARDIOGRAM T WAVE ABNORMAL 7 0.0045
237 VENOOCCLUSIVE DISEASE 11 0.0044
238 PERITONEAL CLOUDY EFFLUENT 6 0.0044
239 NORMOCHROMIC NORMOCYTIC ANAEMIA 13 0.0043
240 MENINGITIS BACTERIAL 6 0.0042
241 ADENOVIRUS INFECTION 12 0.0041
242 FOOT AMPUTATION 6 0.0041
243 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 32 0.0041
244 FEBRILE NEUTROPENIA 273 0.0041
245 CORNEAL DISORDER 9 0.0041
246 HYPERNATRAEMIA 20 0.0040
247 BACTERAEMIA 47 0.0040
248 ENDOCARDITIS 20 0.0039
249 CHRONIC GRAFT VERSUS HOST DISEASE 14 0.0039
250 PNEUMOMEDIASTINUM 7 0.0039
251 CAPILLARY LEAK SYNDROME 8 0.0039
252 PERITONITIS BACTERIAL 39 0.0039
253 PRODUCT DEPOSIT 6 0.0038
254 CLOSTRIDIAL INFECTION 13 0.0038
255 TRANSFUSION 40 0.0038
256 ILEUS PARALYTIC 17 0.0038
257 STATUS EPILEPTICUS 43 0.0038
258 NEONATAL DISORDER 6 0.0038
259 PUPILLARY REFLEX IMPAIRED 7 0.0038
260 INTESTINAL ULCER 6 0.0038
261 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
262 AREFLEXIA 10 0.0037
263 ANTIPHOSPHOLIPID SYNDROME 6 0.0037
264 ABSCESS 59 0.0037
265 NERVE COMPRESSION 34 0.0037
266 HYPERCAPNIA 11 0.0036
267 OTITIS MEDIA 12 0.0036
268 RASH MORBILLIFORM 10 0.0036
269 HYPOALBUMINAEMIA 28 0.0036
270 RESPIRATORY FAILURE 261 0.0036
271 CYTOMEGALOVIRUS INFECTION 59 0.0035
272 PERITONITIS 73 0.0035
273 FIXED ERUPTION 6 0.0035
274 AMYLOIDOSIS 6 0.0035
275 HAEMOLYTIC ANAEMIA 31 0.0035
276 NEUROLOGICAL DECOMPENSATION 8 0.0035
277 ACUTE RESPIRATORY DISTRESS SYNDROME 61 0.0034
278 MYOCLONUS 41 0.0034
279 BACTERIAL INFECTION 64 0.0034
280 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 9 0.0034
281 VOCAL CORD PARALYSIS 6 0.0033
282 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25 0.0033
283 VASCULAR DEVICE INFECTION 15 0.0033
284 PNEUMONIA BACTERIAL 30 0.0033
285 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0033
286 PNEUMOPERITONEUM 6 0.0032
287 HEPATOCELLULAR INJURY 46 0.0032
288 RETROPERITONEAL HAEMORRHAGE 8 0.0032
289 NECROSIS 18 0.0032
290 ASCITES 95 0.0032
291 OLIGURIA 20 0.0032
292 PANCYTOPENIA 180 0.0032
293 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 7 0.0032
294 HYPERURICAEMIA 13 0.0032
295 HEPATOMEGALY 31 0.0032
296 HYPERCOAGULATION 6 0.0031
297 BLOOD BILIRUBIN INCREASED 85 0.0031
298 CHOLESTATIC LIVER INJURY 7 0.0031
299 HEPATIC CYTOLYSIS 40 0.0031
300 GAMMA-GLUTAMYLTRANSFERASE INCREASED 69 0.0031
301 BONE EROSION 11 0.0031
302 GASTROINTESTINAL NECROSIS 9 0.0031
303 CONJUNCTIVAL HYPERAEMIA 11 0.0031
304 NEUROTOXICITY 54 0.0031
305 ACUTE GRAFT VERSUS HOST DISEASE 14 0.0031
306 SHOCK 70 0.0030
307 PNEUMONIA FUNGAL 12 0.0030
308 PNEUMONIA STAPHYLOCOCCAL 6 0.0030
309 RENAL FAILURE ACUTE 128 0.0030
310 TRANSPLANT REJECTION 24 0.0030
311 DEVICE RELATED INFECTION 46 0.0030
312 PNEUMOCYSTIS JIROVECII PNEUMONIA 30 0.0030
313 PULMONARY FUNCTION TEST DECREASED 13 0.0030
314 ADRENAL INSUFFICIENCY 36 0.0030
315 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
316 LUNG INFILTRATION 26 0.0029
317 ARTHRITIS BACTERIAL 12 0.0029
318 HYPOGAMMAGLOBULINAEMIA 19 0.0029
319 SERUM SICKNESS 8 0.0029
320 ACUTE PULMONARY OEDEMA 16 0.0028
321 ENCEPHALOPATHY 70 0.0028
322 SERUM FERRITIN INCREASED 15 0.0028
323 VISUAL ACUITY REDUCED 94 0.0028
324 RESPIRATORY DISTRESS 78 0.0028
325 BLOOD UREA INCREASED 47 0.0028
326 STEM CELL TRANSPLANT 7 0.0028
327 HYPERPHOSPHATAEMIA 6 0.0028
328 ANURIA 24 0.0028
329 POOR QUALITY DRUG ADMINISTERED 18 0.0028
330 HEPATIC LESION 12 0.0028
331 TOXIC ENCEPHALOPATHY 14 0.0028
332 ACUTE RESPIRATORY FAILURE 53 0.0028
333 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
334 AORTIC ARTERIOSCLEROSIS 7 0.0027
335 BLOOD ALKALINE PHOSPHATASE INCREASED 67 0.0027
336 DISTRIBUTIVE SHOCK 6 0.0026
337 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
338 BRONCHOPNEUMONIA 9 0.0026
339 INFLAMMATORY MARKER INCREASED 13 0.0026
340 HYPERLACTACIDAEMIA 7 0.0026
341 CYTOMEGALOVIRUS COLITIS 6 0.0026
342 BLOOD SODIUM INCREASED 7 0.0026
343 INJECTION SITE EXTRAVASATION 32 0.0026
344 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
345 NEPHROPATHY TOXIC 29 0.0026
346 ELECTROLYTE IMBALANCE 30 0.0026
347 BICYTOPENIA 5 0.0025
348 LYMPHOPENIA 36 0.0025
349 GLUCOSE TOLERANCE IMPAIRED 15 0.0025
350 IRIDOCYCLITIS 8 0.0025
351 C-REACTIVE PROTEIN INCREASED 92 0.0025
352 BONE MARROW FAILURE 51 0.0025
353 LUNG CONSOLIDATION 7 0.0025
354 TUMOUR LYSIS SYNDROME 22 0.0025
355 CANDIDIASIS 10 0.0025
356 CYTOKINE RELEASE SYNDROME 50 0.0025
357 PURPURA 22 0.0025
358 GLOMERULONEPHRITIS 6 0.0024
359 NEUTROPENIA 331 0.0024
360 DEAFNESS NEUROSENSORY 8 0.0024
361 STEVENS-JOHNSON SYNDROME 54 0.0024
362 STAPHYLOCOCCAL INFECTION 80 0.0024
363 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 8 0.0024
364 COMA SCALE ABNORMAL 7 0.0024
365 HYPOXIA 85 0.0024
366 SEPSIS 269 0.0024
367 EPSTEIN-BARR VIRUS INFECTION 15 0.0024
368 EOSINOPHIL COUNT INCREASED 20 0.0024
369 DERMATITIS EXFOLIATIVE 12 0.0024
370 HYPOKALAEMIA 110 0.0024
371 HAEMODIALYSIS 20 0.0024
372 NEUTROPENIC SEPSIS 17 0.0024
373 CYTOPENIA 29 0.0024
374 THROMBOTIC MICROANGIOPATHY 23 0.0024
375 HYPERTHERMIA 18 0.0024
376 HEPATOSPLENOMEGALY 6 0.0023
377 MIXED LIVER INJURY 7 0.0023
378 HYPOPHOSPHATAEMIA 17 0.0023
379 VENOUS THROMBOSIS 9 0.0023
380 TYPE I HYPERSENSITIVITY 8 0.0023
381 DEPRESSIVE SYMPTOM 8 0.0023
382 NEONATAL RESPIRATORY DISTRESS SYNDROME 8 0.0023
383 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
384 MENINGITIS 15 0.0022
385 CLOSTRIDIUM DIFFICILE INFECTION 49 0.0022
386 BACTERIAL TEST POSITIVE 5 0.0022
387 BREATH SOUNDS ABNORMAL 11 0.0022
388 RESPIRATORY RATE DECREASED 7 0.0022
389 COLITIS ISCHAEMIC 15 0.0022
390 HEPATIC FAILURE 67 0.0022
391 BONE LESION 8 0.0022
392 SHOCK HAEMORRHAGIC 18 0.0022
393 LARGE INTESTINAL ULCER 6 0.0022
394 PERIPHERAL ISCHAEMIA 9 0.0022
395 LEUKOPENIA 110 0.0022
396 RASH PUSTULAR 16 0.0022
397 PNEUMONIA VIRAL 7 0.0022
398 TYPE IV HYPERSENSITIVITY REACTION 6 0.0022
399 MELAENA 48 0.0022
400 INTESTINAL ISCHAEMIA 12 0.0022
401 RENAL IMPAIRMENT 182 0.0022
402 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
403 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
404 SKIN NECROSIS 11 0.0021
405 NEUTROPHIL COUNT DECREASED 86 0.0021
406 CONCOMITANT DISEASE AGGRAVATED 13 0.0021
407 ACUTE KIDNEY INJURY 322 0.0021
408 NEUROLOGICAL SYMPTOM 12 0.0021
409 TONGUE OEDEMA 8 0.0021
410 HYPOMAGNESAEMIA 29 0.0021
411 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
412 WOUND DEHISCENCE 7 0.0021
413 ALANINE AMINOTRANSFERASE INCREASED 127 0.0021
414 HAEMOTHORAX 6 0.0021
415 METABOLIC DISORDER 12 0.0021
416 HEPATIC FUNCTION ABNORMAL 77 0.0021
417 THROMBOCYTOPENIA 230 0.0021
418 CARDIOPULMONARY FAILURE 8 0.0020
419 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0020
420 HYPERVOLAEMIA 10 0.0020
421 HYDROCEPHALUS 11 0.0020
422 BLOOD ALBUMIN DECREASED 16 0.0020
423 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 10 0.0020
424 AZOTAEMIA 8 0.0020
425 FOLLICULITIS 21 0.0020
426 METABOLIC ENCEPHALOPATHY 6 0.0020
427 SUSPECTED OFF LABEL USE 9 0.0020
428 AGRANULOCYTOSIS 37 0.0020
429 BRADYPHRENIA 13 0.0020
430 LEUKOCYTOSIS 36 0.0020
431 TACHYPNOEA 27 0.0020
432 LYMPHOCYTE COUNT DECREASED 35 0.0020
433 EYE PAIN 111 0.0020
434 ACIDOSIS 15 0.0020
435 ISCHAEMIA 9 0.0020
436 BRONCHIECTASIS 13 0.0019
437 GASTROINTESTINAL PERFORATION 8 0.0019
438 PETECHIAE 20 0.0019
439 TORSADE DE POINTES 15 0.0019
440 HYPOCALCAEMIA 36 0.0019
441 HYPERPYREXIA 8 0.0019
442 INCREASED APPETITE 36 0.0019
443 LEUKOENCEPHALOPATHY 7 0.0019
444 HYPERTRIGLYCERIDAEMIA 11 0.0019
445 ATELECTASIS 18 0.0019
446 MYELOSUPPRESSION 67 0.0019
447 HYPOVENTILATION 6 0.0018
448 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
449 SINUS TACHYCARDIA 26 0.0018
450 FUNGAL INFECTION 61 0.0018
451 HEPATITIS CHOLESTATIC 11 0.0018
452 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0018
453 RETINAL HAEMORRHAGE 13 0.0018
454 ANXIETY DISORDER 6 0.0018
455 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
456 RESPIRATORY ACIDOSIS 7 0.0018
457 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 9 0.0018
458 SINUS BRADYCARDIA 17 0.0018
459 PLEURAL EFFUSION 107 0.0018
460 HAEMOGLOBIN INCREASED 8 0.0018
461 ECCHYMOSIS 12 0.0017
462 ORAL CANDIDIASIS 23 0.0017
463 ENCEPHALITIS 12 0.0017
464 GRANULOMA 6 0.0017
465 ACUTE MYELOID LEUKAEMIA 27 0.0017
466 URINE OUTPUT DECREASED 15 0.0017
467 BLOOD LACTIC ACID INCREASED 9 0.0017
468 DELIRIUM 59 0.0017
469 DRUG LEVEL INCREASED 28 0.0017
470 METABOLIC ACIDOSIS 54 0.0017
471 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
472 CARDIAC TAMPONADE 8 0.0017
473 HYPERKALAEMIA 59 0.0017
474 ELECTROCARDIOGRAM QT PROLONGED 60 0.0017
475 KIDNEY TRANSPLANT REJECTION 8 0.0017
476 DERMATITIS BULLOUS 12 0.0017
477 BONE MARROW DISORDER 5 0.0017
478 PNEUMOTHORAX 26 0.0016
479 PARADOXICAL DRUG REACTION 6 0.0016
480 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
481 TRANSAMINASES INCREASED 36 0.0016
482 OCULAR ICTERUS 7 0.0016
483 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
484 CARDIOGENIC SHOCK 23 0.0016
485 INTERVERTEBRAL DISC PROTRUSION 35 0.0016
486 BLOOD CREATININE DECREASED 5 0.0016
487 DRUG-INDUCED LIVER INJURY 50 0.0016
488 LARGE INTESTINE PERFORATION 11 0.0016
489 BRAIN OEDEMA 20 0.0016
490 DRUG ERUPTION 28 0.0016
491 GASTROENTERITIS 23 0.0016
492 PYREXIA 545 0.0016
493 EYE INFLAMMATION 15 0.0016
494 NO THERAPEUTIC RESPONSE 19 0.0016
495 PANCREATITIS ACUTE 35 0.0016
496 RHINOVIRUS INFECTION 6 0.0015
497 HYPERCALCAEMIA 19 0.0015
498 HERPES SIMPLEX 10 0.0015
499 ORAL INFECTION 6 0.0015
500 WOUND SECRETION 6 0.0015
501 VENTRICULAR FIBRILLATION 17 0.0015
502 ILEUS 19 0.0015
503 POLYP 10 0.0015
504 PNEUMONIA ASPIRATION 38 0.0015
505 NEPHROGENIC ANAEMIA 7 0.0015
506 PROTHROMBIN TIME PROLONGED 9 0.0015
507 BLOOD CREATININE INCREASED 98 0.0015
508 PYELONEPHRITIS 13 0.0015
509 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
510 ORGAN FAILURE 6 0.0015
511 CYSTITIS HAEMORRHAGIC 6 0.0015
512 IMMUNOSUPPRESSION 13 0.0015
513 DECUBITUS ULCER 12 0.0015
514 COMA 70 0.0015
515 PNEUMONITIS 40 0.0015
516 PREMATURE BABY 44 0.0015
517 LEG AMPUTATION 6 0.0015
518 HYPERKERATOSIS 8 0.0014
519 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
520 INFUSION SITE EXTRAVASATION 9 0.0014
521 TROPONIN INCREASED 11 0.0014
522 CONGESTIVE CARDIOMYOPATHY 6 0.0014
523 PLATELET COUNT DECREASED 153 0.0014
524 MALNUTRITION 16 0.0014
525 BLOOD POTASSIUM DECREASED 43 0.0014
526 HALLUCINATIONS, MIXED 6 0.0014
527 LIVER INJURY 35 0.0014
528 RETINAL DETACHMENT 13 0.0014
529 MUCOUS STOOLS 7 0.0014
530 AORTIC VALVE INCOMPETENCE 6 0.0014
531 ABDOMINAL TENDERNESS 7 0.0014
532 RENAL FAILURE 187 0.0014
533 GRANULOCYTOPENIA 8 0.0014
534 HYPOTONIA 14 0.0014
535 BRONCHOSPASM 20 0.0014
536 ACUTE HEPATIC FAILURE 19 0.0014
537 HYPONATRAEMIA 78 0.0014
538 PATHOLOGICAL FRACTURE 7 0.0014
539 HYPOVOLAEMIA 8 0.0014
540 HYPOTENSION 271 0.0013
541 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
542 POLYURIA 11 0.0013
543 NYSTAGMUS 7 0.0013
544 LIVER FUNCTION TEST ABNORMAL 38 0.0013
545 LIPASE INCREASED 10 0.0013
546 PULMONARY FIBROSIS 25 0.0013
547 JAUNDICE 35 0.0013
548 RENAL FAILURE CHRONIC 10 0.0013
549 DIVERTICULITIS 36 0.0013
550 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
551 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
552 HAEMATURIA 44 0.0013
553 HYPOTHERMIA 13 0.0013
554 SPLENOMEGALY 15 0.0013
555 DRUG LEVEL DECREASED 13 0.0013
556 CYANOSIS 20 0.0013
557 CHRONIC LYMPHOCYTIC LEUKAEMIA 6 0.0013
558 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
559 HAEMATOTOXICITY 12 0.0013
560 COAGULOPATHY 21 0.0013
561 CHOLECYSTITIS 15 0.0013
562 URINARY RETENTION 42 0.0013
563 LOW BIRTH WEIGHT BABY 10 0.0013
564 STREPTOCOCCAL INFECTION 7 0.0013
565 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
566 MACULAR OEDEMA 7 0.0012
567 LUNG DISORDER 61 0.0012
568 CARDIOTOXICITY 11 0.0012
569 MOUTH HAEMORRHAGE 9 0.0012
570 VENTRICULAR SEPTAL DEFECT 7 0.0012
571 HAEMOPTYSIS 34 0.0012
572 CARDIOMYOPATHY 18 0.0012
573 HYPOGLYCAEMIA 59 0.0012
574 HERPES VIRUS INFECTION 7 0.0012
575 VENTRICULAR TACHYCARDIA 20 0.0012
576 PERICARDIAL EFFUSION 28 0.0012
577 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
578 PRODUCTIVE COUGH 57 0.0012
579 RASH ERYTHEMATOUS 57 0.0012
580 DYSPHORIA 6 0.0012
581 DIARRHOEA HAEMORRHAGIC 11 0.0012
582 DRUG TOXICITY 16 0.0012
583 BLOOD POTASSIUM INCREASED 19 0.0012
584 HAEMOLYSIS 9 0.0012
585 ANAEMIA 222 0.0012
586 SKIN HYPERPIGMENTATION 10 0.0012
587 EJECTION FRACTION DECREASED 18 0.0012
588 CARDIAC MURMUR 10 0.0012
589 STOMATITIS 70 0.0012
590 PULMONARY MASS 17 0.0011
591 PREMATURE DELIVERY 18 0.0011
592 CONDITION AGGRAVATED 343 0.0011
593 HEPATOTOXICITY 25 0.0011
594 PULMONARY OEDEMA 50 0.0011
595 MENTAL STATUS CHANGES 31 0.0011
596 INTERSTITIAL LUNG DISEASE 54 0.0011
597 MYOSITIS 10 0.0011
598 COVID-19 PNEUMONIA 13 0.0011
599 ATAXIA 13 0.0011
600 PROCTALGIA 7 0.0011
601 WHITE BLOOD CELL COUNT DECREASED 117 0.0011
602 HYPERTENSIVE CRISIS 12 0.0011
603 HEPATITIS ACUTE 7 0.0011
604 HEPATIC ENCEPHALOPATHY 10 0.0011
605 DRUG INTERACTION 170 0.0011
606 BLOOD CALCIUM DECREASED 12 0.0011
607 HEMIPARESIS 18 0.0011
608 CHOLECYSTITIS ACUTE 6 0.0011
609 NEUTROPHILIA 6 0.0011
610 SPUTUM DISCOLOURED 10 0.0011
611 CARDIAC ARREST 87 0.0011
612 OSTEOMYELITIS 19 0.0010
613 TACHYCARDIA 93 0.0010
614 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
615 ENTEROCOLITIS 6 0.0010
616 RALES 6 0.0010
617 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
618 ACUTE MYOCARDIAL INFARCTION 30 0.0010
619 VITREOUS FLOATERS 10 0.0010
620 RESPIRATORY RATE INCREASED 9 0.0010
621 PLEURISY 6 0.0010
622 CARDIAC FAILURE 81 0.0010
623 HYPERTRANSAMINASAEMIA 7 0.0010
624 PLATELET COUNT INCREASED 13 0.0010
625 HERPES ZOSTER 57 0.0010
626 DISEASE PROGRESSION 117 0.0010
627 TOOTH ABSCESS 10 0.0010
628 FOETAL EXPOSURE DURING PREGNANCY 79 0.0010
629 LUNG INFECTION 15 0.0010
630 HYPERGLYCAEMIA 35 0.0010
631 HAEMATOCRIT DECREASED 19 0.0010
632 MOUTH ULCERATION 20 0.0009
633 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 16 0.0009
634 PNEUMONIA 305 0.0009
635 RESPIRATORY DISORDER 28 0.0009
636 THERAPY NON-RESPONDER 42 0.0009
637 END STAGE RENAL DISEASE 17 0.0009
638 ANAPHYLACTIC SHOCK 24 0.0009
639 CARDIAC OPERATION 8 0.0009
640 PRODUCT PREPARATION ERROR 19 0.0009
641 OEDEMA 50 0.0009
642 DIALYSIS 13 0.0009
643 THERAPEUTIC RESPONSE DECREASED 55 0.0009
644 APNOEA 7 0.0009
645 OSTEOARTHRITIS 38 0.0009
646 FLUID OVERLOAD 13 0.0009
647 POST PROCEDURAL COMPLICATION 17 0.0009
648 BODY TEMPERATURE INCREASED 18 0.0009
649 TRICUSPID VALVE INCOMPETENCE 7 0.0009
650 CIRCULATORY COLLAPSE 15 0.0009
651 DEAFNESS 23 0.0009
652 LIVER DISORDER 39 0.0009
653 ATRIAL FLUTTER 7 0.0009
654 SKIN LESION 24 0.0009
655 INFECTION 126 0.0009
656 RHINITIS 7 0.0009
657 HEPATITIS 22 0.0009
658 HALLUCINATION, VISUAL 18 0.0009
659 RASH PAPULAR 19 0.0008
660 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
661 WHEEZING 50 0.0008
662 LACTIC ACIDOSIS 27 0.0008
663 INFLAMMATION 43 0.0008
664 NERVOUS SYSTEM DISORDER 26 0.0008
665 CHILLS 96 0.0008
666 INFUSION RELATED REACTION 54 0.0008
667 RASH GENERALISED 21 0.0008
668 ORAL PAIN 18 0.0008
669 HYDRONEPHROSIS 6 0.0008
670 OFF LABEL USE 696 0.0008
671 MANIA 13 0.0008
672 NEUTROPHIL COUNT INCREASED 8 0.0008
673 ANAPHYLACTIC REACTION 43 0.0008
674 CELLULITIS 39 0.0008
675 HAEMATOMA 20 0.0008
676 FACE OEDEMA 13 0.0008
677 LIP DRY 7 0.0008
678 VENTRICULAR EXTRASYSTOLES 8 0.0008
679 HAEMOGLOBIN DECREASED 79 0.0008
680 GASTROINTESTINAL INFLAMMATION 6 0.0008
681 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
682 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
683 NEPHROPATHY 7 0.0007
684 TREATMENT FAILURE 62 0.0007
685 DISEASE RECURRENCE 35 0.0007
686 SKIN EXFOLIATION 62 0.0007
687 GENERAL PHYSICAL HEALTH DETERIORATION 85 0.0007
688 IMPAIRED GASTRIC EMPTYING 10 0.0007
689 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
690 CARDIOMEGALY 9 0.0007
691 SMALL INTESTINAL OBSTRUCTION 9 0.0007
692 WOUND INFECTION 8 0.0007
693 NEUROPATHY PERIPHERAL 69 0.0007
694 PULMONARY HYPERTENSION 15 0.0007
695 GASTROINTESTINAL HAEMORRHAGE 60 0.0007
696 BRADYCARDIA 38 0.0007
697 ATRIAL SEPTAL DEFECT 6 0.0007
698 BLOOD TEST ABNORMAL 10 0.0007
699 MUSCLE ATROPHY 9 0.0007
700 MITRAL VALVE INCOMPETENCE 8 0.0007
701 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 50 0.0007
702 SALIVARY HYPERSECRETION 7 0.0007
703 HEPATIC STEATOSIS 13 0.0007
704 APHASIA 21 0.0007
705 GASTROINTESTINAL DISORDER 62 0.0007
706 HYPOTHYROIDISM 22 0.0007
707 SPINAL OSTEOARTHRITIS 6 0.0007
708 PULMONARY CONGESTION 9 0.0007
709 DRUG INEFFECTIVE 893 0.0007
710 BLINDNESS 27 0.0007
711 PRODUCT USE IN UNAPPROVED INDICATION 164 0.0007
712 COLITIS 25 0.0007
713 DISORIENTATION 26 0.0007
714 CEREBRAL INFARCTION 16 0.0007
715 EPILEPSY 20 0.0007
716 UROSEPSIS 6 0.0006
717 CONJUNCTIVITIS 12 0.0006
718 ERYTHEMA MULTIFORME 6 0.0006
719 OXYGEN SATURATION DECREASED 36 0.0006
720 CONFUSIONAL STATE 103 0.0006
721 OEDEMA PERIPHERAL 77 0.0006
722 SKIN INFECTION 7 0.0006
723 INTESTINAL PERFORATION 7 0.0006
724 OCULAR DISCOMFORT 7 0.0006
725 TOXICITY TO VARIOUS AGENTS 105 0.0006
726 ANOREXIA 8 0.0006
727 NIGHT SWEATS 20 0.0006
728 REBOUND EFFECT 7 0.0006
729 MYOCARDIAL ISCHAEMIA 7 0.0006
730 CONVULSION 35 0.0006
731 SYNOVITIS 11 0.0006
732 GASTRIC HAEMORRHAGE 7 0.0006
733 ACUTE CORONARY SYNDROME 5 0.0006
734 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
735 HAEMATEMESIS 15 0.0006
736 HYPOPHAGIA 15 0.0006
737 GINGIVAL BLEEDING 8 0.0006
738 TOOTH DISORDER 13 0.0006
739 HALLUCINATION 44 0.0006
740 SWELLING FACE 38 0.0006
741 OSTEOPOROSIS 24 0.0006
742 LYMPHOMA 9 0.0006
743 RESPIRATORY TRACT INFECTION 15 0.0006
744 NEURALGIA 14 0.0006
745 ATRIAL FIBRILLATION 56 0.0006
746 ABDOMINAL PAIN 133 0.0006
747 GLAUCOMA 11 0.0006
748 ANHEDONIA 15 0.0006
749 GASTRITIS 15 0.0006
750 HEART RATE INCREASED 56 0.0006
751 LYMPHADENOPATHY 20 0.0006
752 ORAL HERPES 11 0.0006
753 RED BLOOD CELL COUNT DECREASED 16 0.0006
754 PRODUCT USE ISSUE 105 0.0006
755 INFLUENZA 62 0.0006
756 FAECES DISCOLOURED 12 0.0006
757 RHABDOMYOLYSIS 23 0.0006
758 PRODUCT PRESCRIBING ISSUE 12 0.0006
759 HEPATIC ENZYME INCREASED 37 0.0005
760 UNRESPONSIVE TO STIMULI 14 0.0005
761 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
762 APPENDICITIS 5 0.0005
763 BLOOD SODIUM DECREASED 10 0.0005
764 OSTEOPENIA 8 0.0005
765 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
766 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
767 ANGIOEDEMA 23 0.0005
768 DEHYDRATION 69 0.0005
769 VASCULITIS 6 0.0005
770 RASH MACULAR 18 0.0005
771 BRONCHITIS 38 0.0005
772 THERAPY PARTIAL RESPONDER 8 0.0005
773 BLOOD PRESSURE DECREASED 34 0.0005
774 SKIN DISORDER 17 0.0005
775 VOMITING 238 0.0005
776 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
777 MATERNAL EXPOSURE DURING PREGNANCY 45 0.0005
778 POLYNEUROPATHY 6 0.0005
779 CHRONIC KIDNEY DISEASE 38 0.0005
780 DECREASED APPETITE 116 0.0005
781 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
782 FEEDING DISORDER 10 0.0005
783 CHOLELITHIASIS 16 0.0005
784 ARRHYTHMIA 23 0.0005
785 URINARY TRACT INFECTION 82 0.0005
786 RASH PRURITIC 26 0.0005
787 PROTEINURIA 9 0.0005
788 MYDRIASIS 6 0.0005
789 PARANOIA 8 0.0005
790 DIPLOPIA 12 0.0005
791 DIARRHOEA 298 0.0005
792 DIABETIC KETOACIDOSIS 11 0.0005
793 CARDIO-RESPIRATORY ARREST 19 0.0005
794 LETHARGY 26 0.0005
795 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
796 EXPOSURE DURING PREGNANCY 28 0.0005
797 HYPERSENSITIVITY 83 0.0004
798 CEREBRAL HAEMORRHAGE 16 0.0004
799 CHROMATURIA 10 0.0004
800 DYSPHAGIA 42 0.0004
801 RECTAL HAEMORRHAGE 19 0.0004
802 DYSPNOEA 250 0.0004
803 HYPOACUSIS 19 0.0004
804 PALLOR 12 0.0004
805 HYPERTENSION 91 0.0004
806 BLINDNESS UNILATERAL 6 0.0004
807 DYSARTHRIA 16 0.0004
808 ASTHENIA 159 0.0004
809 COUGH 118 0.0004
810 PRODUCT PRESCRIBING ERROR 10 0.0004
811 PERICARDITIS 7 0.0004
812 RASH 178 0.0004
813 SKIN HAEMORRHAGE 6 0.0004
814 TREATMENT NONCOMPLIANCE 22 0.0004
815 EPISTAXIS 30 0.0004
816 PULMONARY EMBOLISM 38 0.0004
817 INTESTINAL OBSTRUCTION 15 0.0004
818 ECONOMIC PROBLEM 6 0.0004
819 OSTEONECROSIS 13 0.0004
820 GALLBLADDER DISORDER 7 0.0004
821 THIRST 7 0.0004
822 CHEST PAIN 72 0.0004
823 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
824 MOVEMENT DISORDER 12 0.0004
825 ABDOMINAL DISTENSION 39 0.0004
826 LIVER FUNCTION TEST INCREASED 8 0.0004
827 VISUAL IMPAIRMENT 46 0.0004
828 CHEST DISCOMFORT 38 0.0004
829 WEIGHT DECREASED 102 0.0004
830 RENAL DISORDER 17 0.0004
831 COGNITIVE DISORDER 17 0.0004
832 RESPIRATORY ARREST 10 0.0004
833 MUSCULAR WEAKNESS 41 0.0004
834 VIRAL INFECTION 12 0.0004
835 BLISTER 20 0.0004
836 DEEP VEIN THROMBOSIS 23 0.0004
837 JOINT SWELLING 42 0.0003
838 ERYTHEMA 70 0.0003
839 AGITATION 25 0.0003
840 SEIZURE 39 0.0003
841 TOOTH LOSS 7 0.0003
842 RENAL INJURY 10 0.0003
843 ASTHMA 38 0.0003
844 RHEUMATOID ARTHRITIS 38 0.0003
845 FEAR 9 0.0003
846 DERMATITIS 7 0.0003
847 DRUG INTOLERANCE 32 0.0003
848 BONE DISORDER 6 0.0003
849 DISCOMFORT 20 0.0003
850 NAUSEA 259 0.0003
851 INJURY 23 0.0003
852 BLOOD PRESSURE INCREASED 50 0.0003
853 OSTEONECROSIS OF JAW 8 0.0003
854 PANCREATITIS 17 0.0003
855 DYSPNOEA EXERTIONAL 12 0.0003
856 URTICARIA 53 0.0003
857 GASTRIC ULCER 6 0.0003
858 DEPRESSION 71 0.0003
859 VERTIGO 19 0.0003
860 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
861 SOMNOLENCE 62 0.0003
862 ABNORMAL BEHAVIOUR 12 0.0003
863 BLOOD PRESSURE ABNORMAL 6 0.0003
864 PRODUCT ADMINISTRATION ERROR 6 0.0003
865 HAEMORRHAGE 31 0.0003
866 THROAT TIGHTNESS 8 0.0003
867 OROPHARYNGEAL PAIN 27 0.0003
868 PRESYNCOPE 7 0.0003
869 WOUND 8 0.0003
870 GAIT DISTURBANCE 54 0.0003
871 WEIGHT INCREASED 62 0.0003
872 LOSS OF CONSCIOUSNESS 35 0.0003
873 BONE PAIN 16 0.0003
874 SKIN ULCER 7 0.0003
875 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
876 MALAISE 113 0.0003
877 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
878 HEART RATE DECREASED 9 0.0003
879 MALIGNANT NEOPLASM PROGRESSION 26 0.0003
880 CATARACT 15 0.0003
881 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
882 DIABETES MELLITUS 19 0.0002
883 COLITIS ULCERATIVE 11 0.0002
884 RESTLESSNESS 9 0.0002
885 HYPERSOMNIA 7 0.0002
886 SINUSITIS 25 0.0002
887 DYSPHONIA 14 0.0002
888 URINARY INCONTINENCE 7 0.0002
889 HAEMATOCHEZIA 13 0.0002
890 TREMOR 39 0.0002
891 CONSTIPATION 51 0.0002
892 PLASMA CELL MYELOMA 9 0.0002
893 MENTAL DISORDER 10 0.0002
894 SPEECH DISORDER 12 0.0002
895 JOINT STIFFNESS 6 0.0002
896 SWOLLEN TONGUE 7 0.0002
897 BACK PAIN 52 0.0002
898 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
899 BONE DENSITY DECREASED 7 0.0002
900 THROAT IRRITATION 10 0.0002
901 OVERDOSE 48 0.0002
902 LIMB INJURY 6 0.0002
903 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
904 PAIN 134 0.0002
905 DYSURIA 8 0.0002
906 COVID-19 38 0.0002
907 PAIN IN JAW 6 0.0002
908 NASOPHARYNGITIS 39 0.0002
909 UNEVALUABLE EVENT 16 0.0002
910 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
911 PRURITUS 81 0.0002
912 LIP SWELLING 7 0.0002
913 BLOOD GLUCOSE DECREASED 10 0.0002
914 MYALGIA 35 0.0002
915 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
916 NEOPLASM PROGRESSION 7 0.0002
917 DRY EYE 10 0.0002
918 ABDOMINAL PAIN UPPER 41 0.0002
919 LACRIMATION INCREASED 6 0.0002
920 NEPHROLITHIASIS 9 0.0002
921 TINNITUS 9 0.0002
922 INTENTIONAL PRODUCT MISUSE 17 0.0002
923 SYNCOPE 19 0.0002
924 OCULAR HYPERAEMIA 9 0.0002
925 BALANCE DISORDER 16 0.0002
926 FEELING HOT 11 0.0002
927 HEADACHE 111 0.0002
928 INSOMNIA 47 0.0002
929 THERAPY CESSATION 9 0.0002
930 ABORTION SPONTANEOUS 7 0.0002
931 THROMBOSIS 14 0.0002
932 DYSKINESIA 7 0.0002
933 HYPERHIDROSIS 22 0.0002
934 PERIPHERAL SWELLING 26 0.0002
935 DEATH 145 0.0002
936 MOBILITY DECREASED 12 0.0002
937 EMOTIONAL DISTRESS 20 0.0002
938 MEDICATION ERROR 9 0.0002
939 CARDIAC FAILURE CONGESTIVE 13 0.0002
940 ARTHRALGIA 67 0.0002
941 HYPOAESTHESIA 24 0.0002
942 AGGRESSION 8 0.0002
943 HOSPITALISATION 24 0.0002
944 RHINORRHOEA 10 0.0002
945 ANXIETY 43 0.0002
946 BLOOD GLUCOSE INCREASED 27 0.0001
947 NECK PAIN 8 0.0001
948 DYSPEPSIA 14 0.0001
949 SWELLING 13 0.0001
950 AMNESIA 9 0.0001
951 VAGINAL HAEMORRHAGE 6 0.0001
952 FALL 46 0.0001
953 NO ADVERSE EVENT 25 0.0001
954 FLUSHING 14 0.0001
955 FLUID RETENTION 7 0.0001
956 NASAL CONGESTION 8 0.0001
957 IRRITABILITY 8 0.0001
958 VISION BLURRED 18 0.0001
959 DIZZINESS 65 0.0001
960 DRUG WITHDRAWAL SYNDROME 11 0.0001
961 UNDERDOSE 9 0.0001
962 INFLUENZA LIKE ILLNESS 10 0.0001
963 FATIGUE 94 0.0001
964 PALPITATIONS 14 0.0001
965 MUSCULOSKELETAL PAIN 6 0.0001
966 PAIN IN EXTREMITY 33 0.0001
967 DRY MOUTH 9 0.0001
968 ABDOMINAL DISCOMFORT 18 0.0001
969 CARDIAC DISORDER 10 0.0001
970 PARAESTHESIA 16 0.0001
971 ILL-DEFINED DISORDER 6 0.0001
972 SKIN BURNING SENSATION 7 0.0001
973 CEREBROVASCULAR ACCIDENT 16 0.0001
974 CONTUSION 9 0.0001
975 ARTHROPATHY 5 0.0001
976 ARTHRITIS 7 0.0001
977 ADVERSE EVENT 8 0.0001
978 MYOCARDIAL INFARCTION 15 0.0001
979 THERAPY INTERRUPTED 6 0.0001
980 ALOPECIA 16 0.0001
981 MUSCULOSKELETAL STIFFNESS 7 0.0001
982 ILLNESS 8 0.0001
983 ADVERSE DRUG REACTION 6 0.0001
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
985 SUICIDAL IDEATION 6 0.0001
986 PRODUCT DOSE OMISSION ISSUE 19 0.0001
987 INCORRECT DOSE ADMINISTERED 14 0.0001
988 MUSCLE SPASMS 10 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
990 FEELING ABNORMAL 13 0.0001
991 MEMORY IMPAIRMENT 7 0.0001
992 PRODUCT QUALITY ISSUE 6 0.0000
993 INJECTION SITE PAIN 8 0.0000